前列腺放疗中神经血管束剂量最小化的挑战与机遇
本研究对20例局限性前列腺癌患者回顾性勾画神经血管束(NVB),使用Erasmus-iCycle自动生成5×7.25 Gy计划,比较非NVB保护、不牺牲靶区覆盖的NVB保护及允许靶区欠剂量的NVB保护方案。不牺牲覆盖的NVB保护显著降低NVB D0.1 cc和Dmean,进一步降低NVB剂量与靶区覆盖降低相关,非共面计划在相似NVB D0.1 cc下靶区覆盖更高但无临床相关获益。
要点
- 不牺牲靶区覆盖的NVB保护计划可行,显著降低NVB D0.1 cc和Dmean。
- 进一步降低NVB D0.1 cc与靶区覆盖降低明确相关,可用Pareto前沿权衡。
- 非共面计划在相似NVB D0.1 cc下靶区覆盖更高,但无临床相关获益。
核心结论
- 不牺牲靶区覆盖的NVB保护是可行的。
- 非共面NVB保护计划虽总体统计学更优,但相比共面计划未发现临床相关获益。
- 进一步保护NVB以靶区覆盖为代价,Pareto前沿可作为临床实践工具。
研究设计与样本
- 对20例既往接受治疗的限制性前列腺癌患者,基于MRI-CT匹配回顾性勾画NVB。
- 所有计划(5×7.25 Gy)使用Erasmus-iCycle自动生成,比较共面与非共面束流布置。
- 不牺牲覆盖的NVB保护(u-NVBsparing)与非NVB保护(non-NVBsparing)比较,允许靶区欠剂量的NVB保护(c-NVBsparing)以Pareto前沿展示。
- 统计显著性(p值<0.05)由Wilcoxon符号秩检验确定。
主要发现
- u-NVBsparing相比non-NVBsparing,共面计划NVB D0.1 cc中位数38.9 vs 42.6 Gy,Dmean中位数25.6 vs 30.0 Gy,均显著降低。
- u-NVBsparing相比non-NVBsparing,非共面计划NVB D0.1 cc中位数38.9 vs 43.3 Gy,Dmean中位数24.7 vs 30.2 Gy,均显著降低。
- c-NVBsparing计划中进一步降低NVB D0.1 cc与靶区覆盖降低明确相关。
- 非共面c-NVBsparing计划在相似NVB D0.1 cc值下,靶区覆盖显著高于共面计划。
关键数值与推荐
- NVB D0.1 cc:u-NVBsparing共面38.9 Gy vs non-NVBsparing共面42.6 Gy。
- NVB D0.1 cc:u-NVBsparing非共面38.9 Gy vs non-NVBsparing非共面43.3 Gy。
- NVB Dmean:u-NVBsparing共面25.6 Gy vs non-NVBsparing共面30.0 Gy。
- NVB Dmean:u-NVBsparing非共面24.7 Gy vs non-NVBsparing非共面30.2 Gy。
- 计划剂量为5×7.25 Gy,统计显著性阈值为p值<0.05。
临床怎么用
- NVB保护可在不牺牲靶区覆盖的情况下实现。
- 进一步降低NVB剂量需权衡靶区覆盖,Pareto前沿可作为临床实践工具。
- 非共面计划虽统计学更优,但未发现临床相关获益。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Radiation damage to the neurovascular bundles (NVB) has been linked to erectile dysfunction after prostate cancer radiotherapy (PCa). NVB sparing using coplanar and non-coplanar automated treatment planning is presented here in two settings: (1) without compromising target coverage, (2) allowing target coverage compromise. MATERIAL AND METHODS: 20 previously treated patients with localized PCa. Based on a MRI-CT match, the NVB were retrospectively delineated. All treatment plans (5 × 7.25 Gy) were automatically generated using Erasmus-iCycle (in-house automated treatment planning algorithm). Non-NVB sparing (non-NVBsparing) plans and NVB sparing plans in two settings were generated: (1) uncompromised NVB sparing (u-NVBsparing; maintaining target coverage) (2) and compromised NVB sparing (c-NVBsparing; allowing target underdosage). Coplanar and non-coplanar beam arrangements were compared. U-NVBsparing was compared to non-NVBsparing. C-NVBsparing plans were visualized in Pareto fronts. Statistical significance (p-value < 0.05) was determined by Wilcoxon signed-rank test. RESULTS: u-NVBsparing compared to non-NVBsparing plans showed statistically significant median reductions in NVB D0.1 cc (38.9 vs 42.6 Gy for coplanar; 38.9 vs 43.3 Gy for non-coplanar) and Dmean (25.6 vs 30.0 Gy for coplanar; 24.7 vs 30.2 Gy for noncoplanar). Further lowering NVB D0.1 cc in c-NVBsparing plans clearly correlated to lower target coverage. Non-coplanar c-NVBsparing plans maintained significantly higher target coverages for similar NVB D0.1 cc values, compared to coplanar plans. CONCLUSION: NVB sparing without compromising target coverage is feasible. No clinically relevant benefit was found for non-coplanar compared to coplanar NVB sparing plans, although overall statistically superior. Further sparing of the NVB comes at the cost of target coverage, for which a Pareto front could be used as a tool in clinical practise.
引用
- Brand VJ, Rossi L, Milder MTW, et al. Challenges and opportunities to minimize the dose in the neurovascular bundles during prostate radiotherapy. Clin Transl Radiat Oncol. 2025. PMID: 40270948. doi:10.1016/j.ctro.2025.100959
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。